Latest News and Press Releases

PETALUMA, Calif., Jan. 26, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA, warrants SNOAW), today announced that the financial results for its fiscal third quarter 2017, ended...

PETALUMA, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the...

U.S. Product Revenue up 43%, Driven by Growth in U.S. Dermatology Oculus Announced Sale of Latin America Assets for $19.5 Million in Cash (see separate press release, issued on October 31,...

Total cash consideration for sale of Latin American business (which is 30% of current Oculus revenue) exceeds Oculus’ current market capitalization of $17 million U.S.Transaction further includes...

PETALUMA, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal second quarter 2017,...

PETALUMA, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...

PETALUMA, Calif., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the...

PETALUMA, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets unique and...

Product Revenue Up 20% Driven by Growth in U.S. Dermatology Dermatology Prescriptions Up 37%, June Quarter over March 2016 Quarter Conference Call Begins at 4:30pm EDT Today PETALUMA, Calif.,...

PETALUMA, Calif., July 19, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal first quarter 2017,...